Chelsea Therapeutics (CHTP) Slashed 20%+ on Trade Resumption
Get Alerts CHTP Hot Sheet
Join SI Premium – FREE
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) has resumed trading and is down 22 percent following an update on Northera.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Waymo Explores Split With Uber - FT
- Bahrain, Kuwait Warplanes Struck Iran in Rare Gulf Retaliation - WSJ
- Scribe Therapeutics indicating open above $29, IPO priced at $15
Create E-mail Alert Related Categories
FDA, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share